Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News scPharmaceuticals Inc SCPH

Healthcare
scPharmaceuticals Inc. is a pharmaceutical company. The Company is focused on developing and commercializing products to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The Company develops, internally and through strategic partnerships, products and solutions that aim to expand and advance the outpatient care of select acute conditions. Its lead... see more

Recent & Breaking News (NDAQ:SCPH)

scPharmaceuticals Inc. Appoints Renowned Heart Failure Specialist William T. Abraham, M.D., to its Board of Directors

GlobeNewswire February 17, 2021

scPharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference

GlobeNewswire February 11, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of scPharmaceuticals Inc. - SCPH

PR Newswire December 10, 2020

Bronstein, Gewirtz & Grossman, LLC Notifies Investors of scPharmaceuticals Inc. (SCPH) Investigation

ACCESSWIRE IA December 8, 2020

scPharmaceuticals Inc. Receives Complete Response Letter from FDA for FUROSCIX®

GlobeNewswire December 7, 2020

scPharmaceuticals to Present at the 3rd Annual Evercore ISI Virtual HealthCONx Conference

GlobeNewswire November 19, 2020

scPharmaceuticals Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update

GlobeNewswire November 16, 2020

scPharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference

GlobeNewswire November 11, 2020

scPharmaceuticals Provides Business Update

Business Wire October 8, 2020

scPharmaceuticals Hosting Key Opinion Leader Call on FUROSCIX® (furosemide) for subcutaneous administration

Business Wire September 17, 2020

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

Business Wire September 3, 2020

scPharmaceuticals Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update

Business Wire August 13, 2020

scPharmaceuticals Announces FDA Acceptance of FUROSCIX® New Drug Application Resubmission

Business Wire July 27, 2020

scPharmaceuticals Appoints Sara Bonstein to Board of Directors

Business Wire July 10, 2020

scPharmaceuticals Announces FUROSCIX® NDA Resubmission

Business Wire July 1, 2020

scPharmaceuticals Announces New Presentation Time for BMO's Virtual 2020 Prescriptions for Success Healthcare Conference

Business Wire June 18, 2020

scPharmaceuticals Inc. to Present at Upcoming Investor Conferences

Business Wire May 28, 2020

scPharmaceuticals Announces Pricing of Public Offering of Common Stock

Business Wire May 20, 2020

scPharmaceuticals Inc. Announces Proposed Underwritten Public Offering of Common Stock

Business Wire May 20, 2020

scPharmaceuticals Inc. Reports First Quarter 2020 Financial Results and Provides Business Update

Business Wire May 12, 2020